Type 2 diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group:The group used Peganum Harmala capsules amount 1 gram for 3 months, every day. Intervention 2: Control group: The group used placebo capsules amount 1 gram for 3 mon
Sponsors
Ghoum University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: type 2 diabetes over three year age group40-75 Distal polyneuropathy resolutions based on questionnaires Michigan HBA1C8% -10%
Exclusion criteria
Exclusion criteria: Kidney,liver,and heart failure based on the tests, history and physical exam High blood pressure more than 180 mm Hg and advanced ; diabetic Retinopathy Pergnancy and lactation History of amputation Fever the recent use of drugs for neuropathy {gabapentin , nortriptyline} ?Consumers of medicines that induce delayed gastric emptying such as: Acarbose, Miglitol, Exenatid, ?benzodiazepines, calcium channel blockers, narcotics, alpha-2 adrenergic receptor agonists such as ?clonidine, tricyclic antidepressants, dopamine agonists, cholinergic muscarinic receptor antagonists, ?Octreotide, phenothiazines, cyclosporine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: pre and early post-treatment. Method of measurement: Based on Labratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Distal polyneuropathy. Timepoint: Before and 3 months after the intervention. Method of measurement: Michigan Questionnaire A. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMuhammad hossein Yusefi
Ghoum University of Medical Sciences
Outcome results
None listed